Welcome to our dedicated page for Premier news (Ticker: PINC), a resource for investors and traders seeking the latest updates and insights on Premier stock.
Premier Inc (PINC) delivers innovative healthcare solutions through supply chain management and data-driven performance optimization. This news hub provides investors and industry professionals with timely updates on the company's strategic initiatives, financial developments, and operational milestones.
Access verified press releases covering earnings reports, technology partnerships, and healthcare system collaborations. Our curated collection includes updates on cost-reduction strategies, clinical analytics advancements, and regulatory compliance matters relevant to both institutional and individual stakeholders.
Key content areas include financial disclosures, supply chain innovations, and healthcare technology deployments. Bookmark this page for streamlined tracking of PINC's market position and alliance network developments within the evolving healthcare landscape.
Premier Inc (NASDAQ:PINC) reported Q4 FY2025 results with total net revenue of $262.9 million, down 12% year-over-year but exceeding company expectations. Q4 GAAP net income from continuing operations was $18.0 million ($0.22 per share), compared to $60.9 million ($0.57 per share) in the prior year.
For full-year FY2025, the company generated operating cash flow of $417.8 million and free cash flow of $180.5 million, both surpassing expectations. The Supply Chain Services segment showed resilience despite contract renewal headwinds, while Performance Services revenue declined 20% YoY.
Looking ahead, Premier provided FY2026 guidance with total net revenue excluding Contigo Health projected at $940 million to $1 billion, adjusted EBITDA of $230-245 million, and adjusted EPS of $1.33-1.43. The company completed a $200 million accelerated share repurchase program and maintains its quarterly dividend of $0.21 per share.
Premier Inc (NASDAQ:PINC), a healthcare improvement company, has announced a quarterly cash dividend of $0.21 per share for Class A common stock. The dividend will be paid on September 15, 2025, to shareholders of record as of September 1, 2025.
Premier Inc (NASDAQ:PINC) has scheduled its fiscal 2025 fourth-quarter and full-year financial results release for Tuesday, August 19, 2025, at 6:30 a.m. ET. The company will host a conference call to discuss the results at 8:00 a.m. ET the same day.
Investors can access the live webcast and replay through Premier's website in the Investors section under Events & Presentations. The replay will be available for one year after the broadcast. For those without internet access, the call can be joined via telephone using the toll-free domestic number (833) 953-2438 or international number (412) 317-5767.
Premier, Inc. (NASDAQ: PINC) has announced the acquisition of IllumiCare, a healthcare technology company specializing in EMR-agnostic clinical decision support (CDS) platforms. IllumiCare's platform integrates clinical and financial data at the point of care, helping providers optimize clinical decisions while managing costs.
The acquired technology is currently utilized by over 82,000 providers and is compatible with more than 50 EMR systems. IllumiCare's flagship product identifies inpatient medication and diagnostic procedures that may lack clinical benefit based on medical standards, while attributing actual supply costs to ordering providers. The platform demonstrates a potential return on investment of up to 10 to one.
Premier will integrate IllumiCare's capabilities into its Stanson Health brand, with the combined solution launching this summer. The enhanced platform will support various healthcare initiatives, including care gap closure, coding accuracy improvement, outpatient risk capture, clinical trial optimization, and value-based payment model success. Financial terms of the acquisition were not disclosed.
Premier Inc. (NASDAQ: PINC) has joined HealthVerity Marketplace™ as a data source, enabling life sciences organizations to access Premier's comprehensive healthcare datasets. The integration provides access to Premier® Healthcare Database (PHD), one of the largest inpatient and outpatient chargemaster databases with over 25 years of history. The partnership allows access to electronic medical record (EMR) data, including de-identified unstructured clinical notes, supporting research across market access, clinical development, and epidemiological studies.
Through this collaboration, researchers can analyze device and drug utilization patterns, track resource usage and outcomes, and generate insights into care quality, safety, and cost. The integration enhances HealthVerity Marketplace's ecosystem, which currently covers 340 million de-identified individuals, enabling HIPAA-compliant data linkage for comprehensive patient journey insights.
Premier Inc (NASDAQ: PINC), a technology-driven healthcare improvement company, has announced its participation in the upcoming BofA Securities Healthcare Conference. The company's management team will engage in a fireside chat on May 13, 2025, at 9:20 a.m. PDT (12:20 p.m. EDT). Interested parties can access both the live audio webcast and a replay of the event through Premier's investor relations website under the Events and Presentations section.
Premier Inc (NASDAQ: PINC), a technology-driven healthcare improvement company, has announced a quarterly cash dividend of $0.21 per share of Class A common stock. The dividend will be distributed to stockholders of record as of June 1, 2025, with payment scheduled no later than June 15, 2025.
Premier Inc (NASDAQ: PINC) announced that its AI-powered application, Stanson Health CodingCare, is Under Construction in Epic's Toolbox. The app, set to launch in late 2025, will be previewed during Epic's XGM (April 28 – May 2, 2025).
The application leverages generative AI to optimize value-based care performance through automated workflows, specifically focusing on identifying Hierarchical Condition Categories (HCC) required by CMS for accurate risk adjustment and reimbursement in Medicare Advantage programs.
Key features include real-time data analysis of clinical charts, suggesting accurate HCC coding opportunities, surfacing undocumented conditions, and streamlining workflows. According to a cited 2020 JAMA study, 39% of HCCs were not fully documented, leading to undercoding and revenue loss for providers.